3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
4
Stomach Neoplasms
3
Gastrointestinal Neoplasms
3
Rectal Neuroendocrine Tumors
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Small Size Gastrointestinal Stromal Tumors
1
Precancerous Conditions
1
Hemorrhage
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Polyps
1
Clinical Stage III Gastric Cancer AJCC v8
1
Benign Colon Tumors
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
fludarabine
4
Cyclophosphamide
4
Cisplatin
4
pembrolizumab
3
atezolizumab
3
Pemetrexed
3
fludarabine phosphate
2
entrectinib
2
durvalumab
2
cobimetinib
2
capmatinib
2
alectinib
2
Whole-Body Irradiation
2
Vemurafenib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Paclitaxel
2
Nivolumab
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
130-nm albumin-bound paclitaxel
2
trametinib
1
spartalizumab
1
ruxolitinib
1
repotrectinib
1
pralsetinib
1
ponatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Endoscopic Mucosal Resection
×
1 year
×
Clear all
No trials found.